Skip to main navigation Skip to search Skip to main content

The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line

  • Xian Jun Fang
  • , Armand Keating
  • , Michele Flowers
  • , Choong Chin Liew
  • , Hema Gupta
  • , Gordon B. Mills
  • , Morris Sherman

Research output: Contribution to journalArticlepeer-review

Abstract

raf oncogenes have been implicated in hepatic carcinogenesis. We studied the effects of the v-raf of murine retrovirus 3611-MSV on the growth and differentiation of a simian virus 40 (SV40)-immortalized rat liver cell line (ALB-8) which maintained many of characteristics of differentiated hepatocytes. Cells were co-transfected with v-raf and the neogene followed by selection with G418 for transfectants. In culture, the expression of v-raf stimulated cell proliferation without altering cell morphology or expression of liver-specific genes: albumin, fibrinogen, α-1-antitrypsin and α-1-acid glycoprotein. The v-raf-transfected cells induced rapidly growing tumors in 100% of nude mice, while control DNA-transfected cells were only weakly tumorigenic, producing slowly growing tumors in 2/7 mice after a long latency. These slowly growing tumors were histologically moderately to well-differentiated hepatocellular carcinomas in which the liver-specific genes were highly expressed. In contrast, v-raf-induced tumors were histologically poorly differentiated and showed a dramatic decline in the expression of the liver-specific genes. In a tumor cell culture established from a v-raf-induced tumor, however, expression of the liver-specific genes was coordinately recovered. These observations indicate that v-raf is capable of inducing progression of SV40-immortalized hepatocytes into highly malignant cells and the progression is accompanied by loss, in vivo, of the hepatic differentiation.

Original languageEnglish (US)
Pages (from-to)669-674
Number of pages6
JournalCarcinogenesis
Volume14
Issue number4
DOIs
StatePublished - Apr 1993
Externally publishedYes

Funding

The authors wish to thank Dr Wenzhi Ren for his secretarial and bibliographic assistance and Drs Ian Wanless and Emmanuel Farber for their discussion about the tumor histology. This work has been supported by a grant from the Medical Research Council of Canada (MA 10175). A.K. is a senior research scientist of the National Cancer Institute of Canada.

FundersFunder number
Medical Research Council CanadaMA 10175

    ASJC Scopus subject areas

    • Cancer Research

    Fingerprint

    Dive into the research topics of 'The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line'. Together they form a unique fingerprint.

    Cite this